company background image
300676 logo

BGI Genomics XSEC:300676 Stock Report

Last Price

CN¥38.95

Market Cap

CN¥14.9b

7D

-0.6%

1Y

-6.1%

Updated

25 Jan, 2025

Data

Company Financials

BGI Genomics Co., Ltd.

XSEC:300676 Stock Report

Market Cap: CN¥14.9b

300676 Stock Overview

Provides genomic sequencing and proteomic services in China and internationally. More details

300676 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Risk Analysis

Earnings have declined by 32% per year over past 5 years


My Notes

Capture your thoughts, links and company narrative

BGI Genomics Co., Ltd. Competitors

China Resources Boya Bio-pharmaceutical GroupLtd

SZSE:300294

CN¥14.6b

Shenzhen Kangtai Biological Products

SZSE:300601

CN¥16.2b

Yantai Dongcheng Pharmaceutical GroupLtd

SZSE:002675

CN¥10.4b

Walvax Biotechnology

SZSE:300142

CN¥18.1b

Price History & Performance

Summary of share price highs, lows and changes for BGI Genomics
Historical stock prices
Current Share PriceCN¥38.95
52 Week HighCN¥56.89
52 Week LowCN¥33.00
Beta0.71
1 Month Change-10.29%
3 Month Change-17.22%
1 Year Change-6.12%
3 Year Change-53.63%
5 Year Change-51.01%
Change since IPO-39.13%

Recent News & Updates

Recent updates

Shareholder Returns

300676CN BiotechsCN Market
7D-0.6%-0.2%0.9%
1Y-6.1%-14.0%11.5%

Return vs Industry: 300676 exceeded the CN Biotechs industry which returned -14% over the past year.

Return vs Market: 300676 underperformed the CN Market which returned 11.5% over the past year.

Price Volatility

Is 300676's price volatile compared to industry and market?
300676 volatility
300676 Average Weekly Movement4.2%
Biotechs Industry Average Movement5.6%
Market Average Movement6.9%
10% most volatile stocks in CN Market10.8%
10% least volatile stocks in CN Market4.1%

Stable Share Price: 300676 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 300676's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19993,752Lijian Zhaowww.bgi.com

BGI Genomics Co., Ltd. provides genomic sequencing and proteomic services in China and internationally. The company offers solutions to various applications, such as basic research covering human, plant, animal, and microbial species; clinical research in human health; genetic testing and screening; drug discovery and development; and agriculture and biodiversity preservation and sustainability. It also provides DNA, RNA, and customized sequencing solutions; and mass spec services, as well as COVID-19 PCR test kits and COVID lab solutions.

BGI Genomics Co., Ltd. Fundamentals Summary

How do BGI Genomics's earnings and revenue compare to its market cap?
300676 fundamental statistics
Market capCN¥14.85b
Earnings (TTM)-CN¥101.62m
Revenue (TTM)CN¥4.03b

3.7x

P/S Ratio

-146.2x

P/E Ratio

Is 300676 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300676 income statement (TTM)
RevenueCN¥4.03b
Cost of RevenueCN¥2.12b
Gross ProfitCN¥1.91b
Other ExpensesCN¥2.01b
Earnings-CN¥101.62m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Apr 26, 2025

Earnings per share (EPS)-0.27
Gross Margin47.30%
Net Profit Margin-2.52%
Debt/Equity Ratio3.5%

How did 300676 perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

-40%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/25 07:24
End of Day Share Price 2025/01/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BGI Genomics Co., Ltd. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yiling ChenGuosen Securities Co., Ltd.
Hanqing ZhuGuosen Securities Co., Ltd.
Jiaxi XuIndustrial Securities Co. Ltd.